Luc Ceugnart is an expert in Oncology at Centre Oscar Lambret (France). Luc Ceugnart has authored 130 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 322 (community average: 125). How the SLR is computed.

LeadR Profile

Luc Ceugnart Centre Oscar Lambret France
322 ScienceLeadR Reputation 322
Network Map

Oncology

Subspecialties: Medical Imaging - Surgery - Dermatology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2002 - 2026

Source: PubMed

Centre Oscar Lambret

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 130

Citations

Citations: 745 1st author: 23 Last author: 34 Unique author: 2


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Ultrasound-guided blue dye localization of a clipped axillary lymph node after neoadjuvant chemotherapy in breast cancer a prospective feasibility study and critical review of axillary localization techniques.
PMID 42035610 — injections, feasibility studies, lymph nodes, breast neoplasms, neoplasms, sentinel lymph node, biopsy, drug therapy, lymph, breast, sentinel lymph node biopsy, dissection, chemotherapy
Surg Oncol20260
Inventory and needs assessment in francophone LMICs for education, screening and optimal management of breast cancer. The ELISA study.
PMID 41791919 — breast neoplasms, needs assessment, neoplasms, enzyme-linked immunosorbent assay, breast, therapeutics, education
Bull Cancer20260
Radiation-Induced Breast Cancer Attributable to Mammography Screening: Estimation for France in 2019.
PMID 41712417 — breast neoplasms, neoplasms, mammography, breast
J Breast Imaging20260
[Prevalence of breast arterial calcification in women who underwent a breast cancer screening in the Hauts-de-France].
PMID 40744767 — breast neoplasms, cardiovascular diseases, neoplasms, breast, prevalence
Bull Cancer20250
Posttreatment MRI to Predict Pathologic Complete Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy.
PMID 40590696 — triple negative breast neoplasms, breast neoplasms, neoplasms, radiology, breast
Radiology20253

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 1

By status:

Completed 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map